Functional genomics, fragile X syndrome, and RNA interference.
Kalidas
Savitha
S
Department of Pharmacology and Center for Basic Neuroscience, The University of Texas Southwestern Medical Center at Dallas, 75390-9111, USA.
Smith
Dean P
DP
D000483:Alleles; D021901:DNA, Intergenic / Q000235:genetics; D015536:Down-Regulation; D051860:Fragile X Messenger Ribonucleoprotein 1; D005600:Fragile X Syndrome / Q000235:genetics* / Q000628:therapy*; D018390:Gene Targeting / Q000379:methods*; D015316:Genetic Therapy / Q000379:methods*; D018392:Genomic Imprinting / Q000235:genetics*; D006801:Humans; D009419:Nerve Tissue Proteins / Q000235:genetics; D010641:Phenotype; D034622:RNA Interference / Q000502:physiology*; D012322:RNA Precursors / Q000235:genetics; D012330:RNA, Double-Stranded / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics*; D016601:RNA-Binding Proteins
D021901:DNA, Intergenic; D051860:Fragile X Messenger Ribonucleoprotein 1; D009419:Nerve Tissue Proteins; D012322:RNA Precursors; D012330:RNA, Double-Stranded; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; C497683:FMR1 protein, human